research 264 CCR5 blockade shows prevention of alopecia areata development as well as improvement of alopecia areata
This study found that orally administering the CCR5 inhibitor Maraviroc improved hair loss in 4 out of 5 mice with alopecia areata and also reduced the development of the condition, evidenced by decreased CCR5+ T-cell infiltration in treated mice.



